Sorry - my post didn't show, here it is (for what it's worth):
I agree with you Caketin. A high rate of T cell response is good (though it would have been interesting to have further data - I presume the response was killer T cells). Lack of antibody response (at least from the independent tests), although the Fraser group did apparently detect antibody responses, but no details how measured (ELISA, neutralising antibody .... ?). Fingers crossed for phase II.
Ann: Admedus announces further data from HSV-2 Trial, page-113
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |